The Boston-based surgical device company LumeN XT announced at the beginning of April the addition of Marc Beer to the company’s team, with him taking on the role of LumeNXT’s Chairman of the Board. Beer brings to the table more than 25 years of experience in areas of development and commercialization in the field of pharmaceuticals, devices, biotechnology, and diagnostics.
About LumeN XT And Its Illumination Platform
LumeN XT is a private company, considered to be a pioneer when it comes to the use of intracavity LED (light emitting diode) illumination. The company focuses on the development of surgical illumination product line in order to help with surgeries that are minimally invasive. LumeNXT’s illumination platform is used as a heat reduction mechanism designed to provide various advantages, such as improved surgical precision, increased workflow efficiency and improved safety via enhanced visualization. Surgeons who are using targeted illumination have pointed out that the, when compared to traditional techniques, the technology enhances flexibility, precision, and visualization.
Taking On The Role Of Chairman of the Board
The seasoned pharmaceuticals executive talked about his new role of Chairman of the Board and about the company in general. Beer stated this pride in working with ELemeNT’s group of surgeon and engineers, describing them as being accomplished and dedicated. He also noted that they are responsible with advancing the field of surgical illumination by using LumeNXT’s technology towards safely performing surgeries. In addition, he believes that the importance of the company’s platform will increase once more surgeries will be performed featuring minimally invasive approaches.
Paul Rhyne, the co-founder of LumeN XT also talked about the new addition to the team, noting that Beer has had high levels of success in working with multiple startup companies, and that his experience is highly valued at LumeN XT.
About Marc Beer
Besides his new role of Chairman of the Board at LumeN XT, Marc Beer also dedicates time to his own company, Renovia, Inc., which he co-founded in August 2016. The company’s goal is to find and deliver digital therapeutic and diagnostic devices to women who suffer from pelvic floor disorders. Prior to LumeN XT and Renovia, Marc Beer worked for a number of companies within the biotechnology industry, making a name for himself and earning a reputation, with a career that spans over more than 25 years.
He worked for Minerva Neurosciences Inc. as the Founding Chairman, Erytech Pharma as a member of the Board of Directors, and was also part of Good Start Genetics, Inc. serving as Founding Chairman. In addition, Beer was the Founding CEO of ViaCell, from 2000 to 2007. Under his leadership, the company saw rapid growth, having over 300 employees, going public in 2005, before being ultimately acquired by PerkinElmer in 2007. Learn more: https://renoviainc.com/leadership/